Study on pharmacokinetics and bioavailability of nirendipine crystal polymorphs in rabbits
Lou Jian-shi
Abstract
Lou Jian-shi
Abstract
OBJECTIVE To study the pharmacokinetics and relative bioavailability of nitrendipine crystal polymorphs in rabbits.METHODS According to the Latin's design,6 rabbits were divided into 3 groups with cross-over design of oral nitrendipine administration I,II and Ⅲ capsules 80 mg·kg-1 respectively.The plasma concentrations were determined by HPLC.The pharmacokinetic parameters were calculated.RESULTS After a single oral dose,the peak plasma concentration(Cmax)of nitrendipine Ⅰ,Ⅱ and Ⅲ were(351.5±18.7),(392.7±50.8),(822.1±39.7)μg·L-1;the peak time(tmax)were(1.72±0.16),(1.83±0.11),(1.81±0.18)h;the half-time(t1/2)were(13.3±3.5),(8.6±1.2),(8.0±2)h;the area under curve(AUC0→t)were(3 635.1±230.8),(2 697.0±209.4),(6 428.6±585.6)h·μg·L-1,respectively.The relative bioavailability of nitrendipine Ⅱ,Ⅲ to nitrendipine Ⅰ were 62.1% and 169.0%.CONCLUSION There was no bioequivalence among nitrendipine polymorphs.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE To study the pharmacokinetics and relative bioavailability of nitrendipine crystal polymorphs in rabbits.METHODS According to the Latin's design,6 rabbits were divided into 3 groups with cross-over design of oral nitrendipine administration I,II and Ⅲ capsules 80 mg·kg-1 respectively.The plasma concentrations were determined by HPLC.The pharmacokinetic parameters were calculated.RESULTS After a single oral dose,the peak plasma concentration(Cmax)of nitrendipine Ⅰ,Ⅱ and Ⅲ were(351.5±18.7),(392.7±50.8),(822.1±39.7)μg·L-1;the peak time(tmax)were(1.72±0.16),(1.83±0.11),(1.81±0.18)h;the half-time(t1/2)were(13.3±3.5),(8.6±1.2),(8.0±2)h;the area under curve(AUC0→t)were(3 635.1±230.8),(2 697.0±209.4),(6 428.6±585.6)h·μg·L-1,respectively.The relative bioavailability of nitrendipine Ⅱ,Ⅲ to nitrendipine Ⅰ were 62.1% and 169.0%.CONCLUSION There was no bioequivalence among nitrendipine polymorphs.
Key concepts: Nitrendipine, Bioavailability, Pharmacokinetics, Bioequivalence, Cmax, Pharmacology, Chemistry, Oral administration